LMAT logo

LeMaitre Vascular (LMAT)

Profile

Full Name

LeMaitre Vascular, Inc.

Ticker Symbol

LMAT

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

October 19, 2006

Indexes

Not included

Website

http://www.lemaitre.com

Employees

651

Key Details

Price

$86.28(+1.90%)

Market cap

Last Dividend

$0.20

TTM Dividend yield

0.79%

Annual revenue

$219.86M(+13.63% YoY)

Annual EPS

$1.93(+44.03% YoY)

PE ratio

44.47

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$86.28
LMAT price is $86.28

30-Day Relative Volume

0.74
LMAT 30-day relative volume is 0.74

Price Performance

Price Most recent change

+1.9%
LMAT price was up +1.9% on Apr 17, 2025

Price YTD change

-6.36%
LMAT price is down -6.36% since January 1st

Price 1-year change

+36.87%
LMAT price is up +36.87% year-on-year

Price 3-year change

+85.51%
LMAT price is up +85.51% over the past 3 years

Price Range

Price All-time high

$109.58
LMAT price is currently -21.26% below its historical high of $109.58

Price 3-year low

$38.32
LMAT price is currently +125.16% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.95B
LMAT market capitalization is $1.95 billion

Market cap 3-year change

+90.64%
LMAT market capitalization is up +90.64% over the past 3 years

Market cap All-time high

$2.44B
LMAT market capitalization is currently -20.31% below its historical high of $2.44 billion

Market cap sector rank

83.46%
LMAT market capitalization is higher than 83.46% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.5%
LMAT shares outstanding is up +0.5% year-on-year

Shares Outstanding 3-Year Change

+2.76%
LMAT shares outstanding is up +2.76% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.82
LMAT beta is 0.82

200-day SMA

$91.40
LMAT price is currently -5.60% below its 200-day simple moving average

50-day SMA

$88.78
LMAT price is currently -2.81% below its 50-day simple moving average

RSI

53.60
LMAT 14-day relative strength index is 53.60

Volume

0.74
LMAT 30-day relative volume is 0.74

ATR

$3.93
LMAT average true range is $3.93

10-day Historical Volatility

48.75%
LMAT 10-day historical volatility is 48.75%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.20
LMAT last dividend was $0.20 per share, with an ex-dividend date of March 13, 2025

Next Dividend

-
LMAT next dividend has not yet been announced

Dividend per share

Dividend per share

$0.64
LMAT annual dividend per share is $0.64

Dividend per share Sector Rank

27.91%
LMAT annual dividend per share is higher than 27.91% of companies in Healthcare sector

Dividend per share 1-Year Change

+14.29%
LMAT annual dividend per share is up +14.29% year-on-year

Dividend per share 3-Year Change

+45.45%
LMAT annual dividend per share is up +45.45% over the past 3 years

Dividend yield

Dividend yield

0.74%
LMAT annual dividend yield is 0.74%

Dividend yield Sector Rank

22.35%
LMAT annual dividend yield is higher than 22.35% of companies in Healthcare sector

Other

Payout ratio

32.65%
LMAT annual payout ratio is 32.65%

Dividends paid

$14.38M
LMAT annual dividends paid is $14.38 million

Free cash flow

$37.16M
LMAT annual free cash flow is $37.16 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$219.86M
LMAT annual revenue is $219.86 million

Revenue Analysts estimate

$239.25M
LMAT annual revenue is currently -8.10% lower than the consensus analysts' forecast

Revenue 1-year change

+13.63%
LMAT annual revenue is up +13.63% year-on-year

Revenue Sector rank

65.17%
LMAT annual revenue is higher than 65.17% of companies in Healthcare sector

EPS

EPS

$1.93
LMAT annual earnings per share is $1.93

EPS Analysts estimate

$2.24
LMAT annual earnings per share is currently -13.71% lower than the consensus analysts' forecast

EPS 1-year change

+44.03%
LMAT annual earnings per share is up +44.03% year-on-year

EPS Sector rank

92.07%
LMAT annual earnings per share is higher than 92.07% of companies in Healthcare sector

Profit

Gross profit

$150.90M
LMAT annual gross profit is $150.90 million

Gross margin

68.63%
LMAT annual gross profit margin is 68.63%

Operating profit

$52.26M
LMAT annual operating income is $52.26 million

Operating margin

23.77%
LMAT annual operating profit margin is 23.77%

Net income

$44.04M
LMAT annual net profit is $44.04 million

Net margin

20.03%
LMAT annual net profit margin is 20.03%

Expenses

Total expenses

$167.61M
LMAT annual total expenses is $167.61 million

Operating expenses

$98.64M
LMAT annual total operating expenses is $98.64 million

Cost of goods sold

$68.96M
LMAT annual cost of goods sold is $68.96 million

Selling, general & administrative expenses

$83.00M
LMAT annual SGA is $83.00 million

Depreciation and amortization

$9.67M
LMAT annual depreciation & amortization is $9.67 million

Interest expense

$205.00K
LMAT annual interest expense is $205.00 thousand

Income tax

$12.84M
LMAT annual income tax is $12.84 million

EBIT & EBITDA

EBIT

$57.08M
LMAT annual earnings before interest & taxes is $57.08 million

EBITDA

$66.75M
LMAT annual EBITDA is $66.75 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$551.82M
LMAT annual total assets is $551.82 million

Non current assets

$149.63M
LMAT annual long term assets is $149.63 million

Current assets

$402.19M
LMAT annual total current assets is $402.19 million

Cash and cash equivalents

$25.61M
LMAT annual cash & cash equivalents is $25.61 million

Accounts receivable

$30.06M
LMAT annual accounts receivable is $30.06 million

Inventory

$55.94M
LMAT annual inventory is $55.94 million

Liabilities

Total liabilities

$214.53M
LMAT annual total liabilities is $214.53 million

Long term liabilities

$183.92M
LMAT annual total long term liabilities is $183.92 million

Current liabilities

$30.61M
LMAT annual total current liabilities is $30.61 million

Accounts payable

$1.76M
LMAT annual accounts payable is $1.76 million

Debt

Total debt

$185.69M
LMAT annual total debt is $185.69 million

Total debt 1-year change

+872.43%
LMAT annual total debt is up +872.43% year-on-year

Long term debt

$183.00M
LMAT annual long term debt is $183.00 million

Short term debt

$2.68M
LMAT annual short term debt is $2.68 million

Equity & Capital

Shareholders equity

$337.29M
LMAT annual stockholders equity is $337.29 million

Book value

$337.29M
LMAT annual book value is $337.29 million

Retained earnings

$145.09M
LMAT annual retained earnings is $145.09 million

Working capital

$371.58M
LMAT annual working capital is $371.58 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$44.12M
LMAT annual cash flow from operations is $44.12 million

Cash from operations 1-year change

+20.06%
LMAT annual cash flow from operations is up +20.06% year-on-year

Cash from investing

-$200.12M
LMAT annual cash flow from investing activities is -$200.12 million

Cash from investing 1-year change

-709.71%
LMAT annual cash flow from investing activities is down -709.71% year-on-year

Cash from financing

$158.10M
LMAT annual cash flow from financing activities is $158.10 million

Cash from financing 1-year change

+2317.11%
LMAT annual cash flow from financing activities is up +2317.11% year-on-year

CAPEX

CAPEX

$6.96M
LMAT annual capital expenditures is $6.96 million

CAPEX 1-year change

-4.17%
LMAT annual capital expenditures is down -4.17% year-on-year

Free Cash Flow

Free cash flow

$37.16M
LMAT annual free cash flow is $37.16 million

Free cash flow 1-year change

+26.03%
LMAT annual free cash flow is up +26.03% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

68.63%
LMAT annual gross profit margin is 68.63%

Operating margin

23.77%
LMAT annual operating profit margin is 23.77%

Net margin

20.03%
LMAT annual net profit margin is 20.03%

ROA & ROE

ROA

9.80%
LMAT annual return on assets is 9.80%

ROE

13.87%
LMAT annual return on equity is 13.87%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

44.47
LMAT price to earnings ratio is 44.47

PE ratio Sector rank

74.51%
LMAT price to earnings ratio is higher than 74.51% of companies in Healthcare sector

PB Ratio

PB ratio

5.77
LMAT price to book ratio is 5.77

PB ratio Sector rank

85.33%
LMAT price to book ratio is higher than 85.33% of companies in Healthcare sector

PS Ratio

PS ratio

8.85
LMAT price to sales ratio is 8.85

PS ratio Sector rank

77.28%
LMAT price to sales ratio is higher than 77.28% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.11B
LMAT enterprise value is $2.11 billion

Enterprise value Sector rank

82.73%
LMAT enterprise value is higher than 82.73% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

31.56
LMAT EV/EBITDA is 31.56

EV/EBITDA Sector rank

95.3%
LMAT EV/EBITDA is higher than 95.3% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

13.14
LMAT annual current ratio is 13.14

Quick ratio

11.31
LMAT annual quick ratio is 11.31

Leverage

Debt to equity

0.50
LMAT annual debt to equity ratio is 0.50

Interest coverage ratio

278.44
LMAT annual interest coverage ratio is 278.44

Risk & Stability

Piotroski F-Score

6
LMAT piotroski f-score is 6

Altman Z-Score

7.36
LMAT altman z-score is 7.36

Analyst ratings

Recent major analysts updates

Feb 28, 25 Lake Street
Buy
Feb 28, 25 Citizens Capital Markets
Buy
Feb 28, 25 Barrington Research
Market Perform
Feb 13, 25 Wells Fargo
Equal-Weight
Nov 1, 24 Oppenheimer
Outperform
Nov 1, 24 Barrington Research
Outperform
Oct 15, 24 Cantor Fitzgerald
Neutral
Sep 20, 24 Barrington Research
Outperform
Aug 20, 24 JMP Securities
Market Outperform
Aug 2, 24 Barrington Research
Outperform

Institutional Ownership

Similar stocks

LIVN logo
LivaNova (LIVN)
APGE logo
Apogee Therapeutics (APGE)
MIRM logo
Mirum Pharmaceuticals (MIRM)
TARS logo
Tarsus Pharmaceuticals (TARS)
BHC logo
Bausch Health Companies (BHC)
SDGR logo
Schrödinger (SDGR)
LGND logo
Ligand Pharmaceuticals Incorporated (LGND)
DNLI logo
Denali Therapeutics (DNLI)
Metsera (MTSR)
  • What is the ticker symbol for LeMaitre Vascular?
  • Does LeMaitre Vascular pay dividends?
  • What sector is LeMaitre Vascular in?
  • What industry is LeMaitre Vascular in?
  • What country is LeMaitre Vascular based in?
  • When did LeMaitre Vascular go public?
  • Is LeMaitre Vascular in the S&P 500?
  • Is LeMaitre Vascular in the NASDAQ 100?
  • Is LeMaitre Vascular in the Dow Jones?
  • When was LeMaitre Vascular's last earnings report?
  • When does LeMaitre Vascular report earnings?
  • Should I buy LeMaitre Vascular stock now?

What is the ticker symbol for LeMaitre Vascular?

The ticker symbol for LeMaitre Vascular is NASDAQ:LMAT

Does LeMaitre Vascular pay dividends?

Yes, LeMaitre Vascular pays dividends. The last payment was $0.20, with an ex-dividend date on March 13, 2025

What sector is LeMaitre Vascular in?

LeMaitre Vascular is in the Healthcare sector

What industry is LeMaitre Vascular in?

LeMaitre Vascular is in the Medical Instruments & Supplies industry

What country is LeMaitre Vascular based in?

LeMaitre Vascular is headquartered in United States

When did LeMaitre Vascular go public?

LeMaitre Vascular's initial public offering (IPO) was on October 19, 2006

Is LeMaitre Vascular in the S&P 500?

No, LeMaitre Vascular is not included in the S&P 500 index

Is LeMaitre Vascular in the NASDAQ 100?

No, LeMaitre Vascular is not included in the NASDAQ 100 index

Is LeMaitre Vascular in the Dow Jones?

No, LeMaitre Vascular is not included in the Dow Jones index

When was LeMaitre Vascular's last earnings report?

LeMaitre Vascular's most recent earnings report was on Feb 27, 2025

When does LeMaitre Vascular report earnings?

The next expected earnings date for LeMaitre Vascular is May 1, 2025

Should I buy LeMaitre Vascular stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page